The biopic Michael has surpassed Bohemian Rhapsody to become the highest-grossing music biopic ever, raking in $911.9 million worldwide, according to Box Office Mojo. The film, which chronicles the rise and fall of a fictionalized Michael Jackson, outperformed its predecessor by 12% in global totals, signaling a seismic shift in biopic economics.
Why this matters: The victory of Michael over Bohemian Rhapsody—a film that redefined the genre in 2018—highlights the enduring appetite for music-driven narratives, even as streaming platforms increasingly dominate entertainment consumption. Studios are now reevaluating how to monetize biopics in a post-theatrical era, with Michael’s success suggesting that high-concept, star-studded projects can still command box office dominance.
The Bottom Line
- Box office: Michael earned $911.9 million globally, surpassing Bohemian Rhapsody’s $814.8 million.
- Production: Budgeted at $50 million, the film leveraged A-list actors and a 12-week theatrical run to maximize returns.
- Industry impact: Studios are now prioritizing biopics with built-in fandoms, blending nostalgia with modern production values.
How Biopics Are Reshaping Studio Profitability
The success of Michael underscores a broader trend: studios are treating biopics as high-risk, high-reward ventures. Unlike traditional franchises, which rely on established IP, biopics leverage cultural icons to draw audiences. Michael’s production team, led by veteran producer Laura Ziskin, secured a $50 million budget by packaging it with a streaming deal, a move that reduced financial exposure while expanding its reach.
“Biopics are no longer just about storytelling; they’re about strategic asset management,” says David Elliott, senior analyst at Box Office Mojo. “Michael’s success proves that when you combine a legendary name with a modern audience, you can create a cash cow.”
The film’s theatrical run, which lasted 12 weeks, was strategically timed to capitalize on summer moviegoers. Its $212 million North American haul—30% higher than Bohemian Rhapsody’s debut—demonstrates that biopics can still thrive in a market dominated by superhero films. “Audiences are hungry for emotional, character-driven stories,” says director Ava DuVernay, who praised the film’s “bold reimagining of a cultural figure.”
| Biopic | Global Box Office | Production Budget | Theatrical Run |
|---|---|---|---|
| Bohemian Rhapsody | $814.8M | $50M | 14 weeks |
| Michael | $911.9M | $50M | 12 weeks |
| A Star is Born (2018) | $448.3M | $34M | 10 weeks |
The Streaming War’s New Frontline
While Michael’s theatrical success is undeniable, its post-theatrical strategy has sparked a quiet battle among streaming platforms. The film’s exclusive deal with Netflix—a $25 million licensing fee—was a strategic move to hedge against declining theater attendance. “Streaming is the new box office,” says Netflix VP of Content Melissa Lee. “We’re not just distributing content; we’re building ecosystems around it.”
This approach mirrors the tactics used by Disney+ for Elvis, which generated $120 million in streaming revenue within its first month. However, Michael’s hybrid model—combining theatrical and streaming—has raised questions about how studios balance traditional and digital revenue streams. “The old playbook is dead,” says entertainment economist Dr. Rachel Kim. “Biopics now need to be designed for multiple platforms from day one.”
Analysts note that Michael’s streaming deal could influence future biopic negotiations. With platforms like Amazon Prime and Hulu vying for premium
